Patients receiving a prescription for diamorphine (heroin) in the United Kingdom

References

• Bammer G. Should the controlled provision of heroin be a treatment option? Australian feasibility considerations. Addiction 1993; 83: 467–475
   Google Scholar
• Bammer G, Dobler-Mikola A, Fleming P M, Strang J, Uchtenhagen A. The heroin prescribing debate:integrating science and politics. Science 1999; 284: 1277–1278
   PubMed Web of Science ®Google Scholar
• Ward J, Mattick R P, Hall W. The effectiveness of methadone maintenance treatment 2: HIV and infectious hepatitis. Methadone maintenance treatment and other opioid replacement therapies, J Ward, R P Mattick, W Hall. Harwood Academic Publishers, Australia 1998; 59–74
   Google Scholar
• Gossop M, Marsden J, Stewart D. NTORS at one year: changes in substance use, health and criminal behaviours one year after intake. Department of Health, London 1999
   Google Scholar
• Thorley A, Oppenheimer E, Stimson G V. Clinic attendance and opiate prescription status of heroin addicts over a six-year period. Br J Psychiatry 1977; 130: 565–569
   PubMedGoogle Scholar
• Stimson G V, Oppenheimer E. Heroin addiction treatment and control in Britain. Tavistock Publications, London 1980
   Google Scholar
• Hartnoll R, Mitcheson M, Battersby A. Evaluation of heroin maintenance in controlled trials. Arch Gen Psychiatry 1980; 37: 877–883
   PubMed Web of Science ®Google Scholar
• Battersby M, Farrell M, Gossop M, Robson P, Strang J. Horse trading—prescribing injectable opiates to opiate addicts. A descriptive study. Drug Alcohol Rev 1992; 11: 35–42
   PubMedGoogle Scholar
• McCusker C, Davies M. Prescribing drug of choice to illicit heroin users: the experience of a UK community drug team. J Subs Abuse Treat 1996; 13: 521–531
   PubMed Web of Science ®Google Scholar
• Metrebian N, Shanahan W, Wells B, Stimson G V. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. Med J Aust 1998; 168: 596–600
   PubMed Web of Science ®Google Scholar
• Metrebian N, Shanahan W, Stimson G V, et al. Prescribing drug of choice to opiate dependent drug users: a comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic. Drug Alcohol Rev 2001; 20: 267–276
   Web of Science ®Google Scholar
• Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blattler R, Pfeifer S. Prescription of narcotics for heroin addicts: main results of Swiss National Cohort Study, vol. 1. Medical prescription of narcotics. Karger, Basel 1999
   Google Scholar
• van den Brink W, Vincent M, Hendricks V M, Blanken P, Huijsman I A, van Ree J N. Medical co-prescription of heroin: two randomised controlled trials. Central Committee on the treatment of Heroin Addicts, Utrecht 2002
   Google Scholar
• Marks J. Opium the religion of the people. Lancet 1985; I: 1439–1440
   Google Scholar
• Marks J. Who killed the British System?. Druglink 1995; 10: 21
   Google Scholar
• Mitcheson M, Hartnoll R. Prescribing heroin: does it work?. Druglink 1990; 5: 10–11
   Google Scholar
• Strang J, Farrell M. Treatment of heroin users. BMJ 1994; 308: 718, [Letter]
   PubMedGoogle Scholar
• Strang J, Gossop M. ‘The British System’: visionary anticipation or masterly inactivity?. Heroin addiction and drug policy: the British system, J Strang, M Gossop. Oxford Medical Publications, Oxford 1994
   Google Scholar
• Zador D. Injectable opiate maintenance in the UK: is it good clinical practice?. Addiction 2001; 96: 547–553
   PubMed Web of Science ®Google Scholar
• National Treatment Agency for Substance Misuse. Injectable heroin (and injectable methadone): potential roles in drug treatment. National Treatment Agency, London 2003
   Google Scholar
• Home Affairs Committee. The government's drug policy: is it working? House of Commons, HC 318-1. HMSO, London 2002
   Google Scholar
• Sell L, Segar G, Merrill J. Patients prescribed injectable opiates in the North West of England. Drug Alcohol Review 2001; 20: 57–66
   Google Scholar
• Sell L, Zador D. Patients prescribed injectable heroin or methadone—their opinions and experiences of treatment. Addiction 2004; 99: 442–449
   PubMed Web of Science ®Google Scholar
• Metrebian N, Carnwath T, Stimson G V, Storz T. Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom. Addiction 2002; 97: 1155–1161
   PubMed Web of Science ®Google Scholar
• Stimson G V, Metrebian N. Prescribing heroin: what is the evidence?. Joseph Rowntree Foundation Drug and Alcohol Research Programme, London 2003
   Google Scholar
• Strang J, Bearn J, Farrell M, et al. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev 1998; 17: 197–211
   PubMed Web of Science ®Google Scholar
• Fountain J, Strang J, Gossop M, Farrell M, Griffiths P. Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction 2000; 95: 393–406
   PubMed Web of Science ®Google Scholar
• Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001; 358: 1417–1423
   PubMed Web of Science ®Google Scholar